These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16709177)

  • 1. The biological relevance of chemokine-proteoglycan interactions.
    Proudfoot AE
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):422-6. PubMed ID: 16709177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.
    Handel TM; Johnson Z; Crown SE; Lau EK; Proudfoot AE
    Annu Rev Biochem; 2005; 74():385-410. PubMed ID: 15952892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
    Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs.
    Potzinger H; Geretti E; Brandner B; Wabitsch V; Piccinini AM; Rek A; Kungl AJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):435-7. PubMed ID: 16709180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of chemokine-glycosaminoglycan interaction specificity.
    Kawashima H
    Methods Enzymol; 2006; 416():254-63. PubMed ID: 17113871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
    Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
    Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors.
    Shaw JP; Johnson Z; Borlat F; Zwahlen C; Kungl A; Roulin K; Harrenga A; Wells TN; Proudfoot AE
    Structure; 2004 Nov; 12(11):2081-93. PubMed ID: 15530372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges.
    Rajarathnam K; Desai UR
    Front Immunol; 2020; 11():660. PubMed ID: 32391006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
    Leach K; Charlton SJ; Strange PG
    Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteoglycan control of cell movement during wound healing and cancer spreading.
    Cattaruzza S; Perris R
    Matrix Biol; 2005 Sep; 24(6):400-17. PubMed ID: 16055321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists.
    Brandner B; Rek A; Diedrichs-Möhring M; Wildner G; Kungl AJ
    Protein Eng Des Sel; 2009 Jun; 22(6):367-73. PubMed ID: 19414521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention.
    Johnson Z; Proudfoot AE; Handel TM
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):625-36. PubMed ID: 15990353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of RANTES by extracellular parts of the CCR5 receptor.
    Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
    J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
    Ivey ME; Little PJ
    Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization.
    Dyer DP; Migliorini E; Salanga CL; Thakar D; Handel TM; Richter RP
    Open Biol; 2017 Jan; 7(1):. PubMed ID: 28123055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
    Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli.
    Cho HJ; Lee Y; Chang RS; Hahm MS; Kim MK; Kim YB; Oh YK
    Protein Expr Purif; 2008 Jul; 60(1):37-45. PubMed ID: 18455434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.
    Lau EK; Paavola CD; Johnson Z; Gaudry JP; Geretti E; Borlat F; Kungl AJ; Proudfoot AE; Handel TM
    J Biol Chem; 2004 May; 279(21):22294-305. PubMed ID: 15033992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.